Jonathan
B. Tucker, PhD
Monterey Institute of International Studies
The threat
of biological and chemical warfare continues to frighten many
Americans. Some people have even taken matters into their own
hands by purchasing antibiotics and/or gas masks.
How grave
is the risk? Will any of these measures really protect us? To
find out, Bottom Line/Health spoke with chemical and biological
weapons expert Jonathan B. Tucker, PhD.
What
are the health risks of a bioterrorist attack? As everyone
knows, a number of cases of anthrax exposure and infection have
already occurred.
Inhalation
anthrax occurs if enough spores of the bacterium Bacillus anthracis
are inhaled. It’s not contagious. Flulike symptoms typically
start within one to seven days of exposure. Inhalation anthrax
should be treated before symptoms begin with an antibiotic,
such as ciprofloxacin (Cipro), penicillin, tetracycline
or doxycycline. Once symptoms develop, the condition is
fatal in more than 80% of cases.
Skin (cutaneous)
anthrax infection results when the bacterium enters cuts or abrasions
in the skin. Although fatal in up to 20% of cases if left untreated,
cutaneous anthrax generally responds well to antibiotics.
The other
agents most likely to be used cause three illnesses.
The first
is botulism. This disease is a type of poisoning caused by a toxin
produced by the bacterium Clostridium botulinum. About
50% of victims die unless treated with an antitoxin.
The second
is pneumonic plague. Caused by the bacterium Yersinia pestis,
the disease causes flulike symptoms and is highly contagious.
It’s deadly in more than 50% of cases unless victims are treated
with antibiotics, such as streptomycin, tetracycline or
gentamicin.
The third
is smallpox. Caused by the variola virus, this disease,
which was eradicated worldwide in 1979, is marked by fever and
a rash that first looks like chicken pox and later turns into
pus-filled lesions. It’s highly contagious if one comes in close
proximity to someone with symptoms, which develop about two weeks
after exposure to the virus. About 30% of patients die unless
they are vaccinated within three to five days after exposure.
No drug treatment is available.
Is
the US government prepared to cope with these types of attacks?
There are adequate stocks of antibiotics to treat anthrax and
plague and antitoxin to treat botulism.
The Centers
for Disease Control and Prevention (CDC) is procuring more smallpox
vaccine to supplement the 15.4 million doses that are currently
available. Fifty-four million additional doses should be available
by next year. In addition, government officials have said they
are negotiating to buy 300 million doses of the vaccine -- enough
for every American.
Still, large
gaps exist in the public and private health systems, which are
the first line of defense against a bioterrorist attack. Doctors
and nurses must be trained how to recognize symptoms and how to
treat them. City, county and state health departments need more
staff and resources. Diagnostic laboratories also need to be outfitted
with the technology to identify infections like anthrax in time
to treat them.
What
can individuals do to protect themselves? If you develop an
unusual illness or skin rash, notify your physician and local
health department at once.
It’s also
a good idea to ask your doctor to take continuing education classes
about the symptoms and treatment of anthrax, smallpox and other
infections.
To educate
physicians, The Journal of the American Medical Association
(JAMA) recently began publishing a series of review articles
on bioterrorism agents. For more information, go to the JAMA Web
site at http://jama.ama-assn.org.
Law-enforcement agencies have urged Americans to be alert. What
exactly does this mean? It is important for individuals to
report any suspicious behavior to the authorities. This means
calling 911 if you see someone leaving a package unattended or
spraying something in a subway, a crowded shopping mall or near
the air-intake system of a building.
The
antibiotic Cipro is FDA-approved for use as an anthrax antidote.
Should I ask my doctor for a prescription just in case? Individuals
should not stockpile antibiotics. Self-administering these
drugs in the absence of anthrax exposure can cause harmful side
effects.
The overuse
of antibiotics increases the resistance of pathogenic bacteria
to these life-saving drugs, making them less effective when they
are really needed.
If
a person understands the importance of not taking an antibiotic,
such as Cipro, unnecessarily, what’s wrong with getting the drug?
If thousands of people stock up on Cipro, they could deplete the
national supply that would be needed in an actual emergency.
In the event
an outbreak of anthrax occurs, the federal government will distribute
Cipro to the affected population within 12 hours. That’s what
happened in the recent cases involving anthrax exposure.
Will
a gas mask protect me in case of an attack? Probably not.
A poison gas, such as sarin, or a biological agent, such as the
bacterium that causes anthrax, is usually odorless and colorless
-- and it’s unlikely that you would have warning that it had been
released. That means to really protect yourself you’d have
to wear the mask all the time, which is impractical.
What
about vaccines for anthrax and/or smallpox? These vaccines
are currently in very limited supply and are only available to
military personnel, who are at far greater risk than civilians.
What’s more, there is concern over possible complications of these
vaccines.
Back in the
1960s, the smallpox vaccine caused serious complications, such
as brain damage and even death, in roughly one of every million
people vaccinated.
It would
make sense to begin vaccinating the US population as a preventive
only if the threat of a terrorist attack with smallpox were so
high that it outweighed the risk of complications from the vaccine.
Currently, that is not the case. But government officials are
increasing supplies of the vaccine in case the situation changes.
If a smallpox outbreak ever occurs, the federal government will
provide smallpox vaccine to individuals exposed to the disease
or at immediate risk.
Fortunately,
the smallpox vaccine works extremely fast, producing full immunity
within 10 days. It is even effective at preventing the disease
or rendering it less severe when administered up to three to five
days after infection.
Jonathan
B. Tucker, PhD, director of the Chemical & Biological Weapons
Nonproliferation Program at the Monterey Institute of International
Studies in Washington, DC. He is the author of Scourge:
The Once and Future Threat of Smallpox (Atlantic Monthly
Press) and Toxic
Terror: Assessing Terrorist Use of Chemical and Biological Weapons
(MIT Press).